Acetazolamide
- Product NDC
- 27241-133
- 11-digit product format
- 272410133
- Labeler code
- 27241
- Product ID
- 27241-133_65c27c82-082a-4995-b44d-641817b4c587
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ajanta Pharma USA Inc.
- Application
- ANDA211151
- Marketing category
- ANDA
- Marketing start
- 2023-09-11
- Substance
- ACETAZOLAMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 197303, 197304 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 27241-133-04 | Acetazolamide | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 27241-133 | ACETAZOLAMIDE TABLET [AJANTA PHARMA USA INC.] | 5 | Current NDC, 1 package rows | 20250418_240ab24b-3124-4805-80c2-36dd1945e3b3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 27241-133-04 | 27241013304 | 100 TABLET in 1 BOTTLE (27241-133-04) | 100 tablet | 2023-09-11 | No | No | Current |